Overview
- FMC said multiple corporate and private-equity parties have shown interest since it began a review that includes a possible sale.
- Investor optimism has driven the stock up roughly 28% this year, reflecting hopes for a takeover premium.
- Management and analysts warn that bidders could walk after reviewing the books, which would leave limited upside and clear downside risk.
- Recent performance has been soft, with comparable 2025 revenue down about 5% and adjusted EPS at $2.96, down 14.9%, muddied by a potential India unit sale and restructuring charges.
- The company logged losses in three of the past four quarters, cut its dividend by 86%, and is exiting India, and the shares sit about 11% above their pre-review level, a setup that often unwinds if no deal happens.